Calprotectin plasma level is elevated in preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 2, 2005, Pages 151-154

  Holthe, Mette Ree ^a   Staff, Anne Cathrine ^a   Berge, Lillian Nordboe ^a   Fagerhol, Magne Kristoffer ^a   Lyberg, Torstein ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Calprotectin; Leukocyte activation; Preeclampsia

Indexed keywords

CALPROTECTIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BODY MASS; CASE CONTROL STUDY; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MYELOMONOCYTIC CELL; MYELOMONOCYTIC LEUKEMIA; NEUTROPHIL; PARITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TROPHOBLAST;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 14044252752     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00554.x     Document Type: Article

References (18)

1. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997; 50: 113-23.
2. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003; 18: 756-62.
3. Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003; 13: 2-21.
4. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
5. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.
6. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
7. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81: 642-8.
8. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand 2001; 80: 1036-8.
9. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci (Colch) 1997; 92: 37-44.
10. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80-6.
11. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001; 185: 792-7.
12. Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998; 41: 316-21.
13. Pocock SJ. Clinical Trials; A Practical Approach. Chichester: Wiley, 1983: 123-41.
14. Holthe MR, Staff AC, Berge LN, Lyberg T. Leukocyte adhesion molecules and reactive oxygen species in preeclampsia. Obstet Gynecol 2004; 103: 913-22.
15. Gallery ED, Campbell S, Arkell J, Nguyen M, Jackson CJ. Preeclamptic decidual microvascular endothelial cells express lower levels of matrix metalloproteinase-1 than normals. Microvasc Res 1999; 57: 340-6.
16. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177: 443-9.
17. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101: 488-92.
18. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994; 13: 103-9.